Available in the shop
- CJC-1295 without DAC 2 mg — $63.00
- CJC-1295 with DAC 2 mg — $126.00
- CJC-1295 without DAC 5 mg — $147.00
- CJC-1295 without DAC 5 mg + Ipamorelin 5 mg — $199.50
- CJC-1295 without DAC 10 mg — $294.00
- CJC-1295 with DAC 5 mg — $294.00
Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.
Identification
| Field of research | Sport and recovery |
|---|---|
| PubChem name | Cjc 1295 |
| Formula | C165H269N47O46 |
| Molecular weight | 3647.2 g/mol |
| CAS number | 446262-90-4 |
| Also known as | 62RC32V9N7, CJC1295, RefChem:918751, GRF 1-29 (CJC1295) |
| PubChem | CID 91971820 |
Summary
CJC-1295 DAC, also known as DAC:GRF, is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsRandomized Controlled TrialResearch Support, Non-U.S. Gov'tTeichman SL, Neale A, Lawrence B et al. · J Clin Endocrinol Metab, 2006 · PMID 16352683 · DOI
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
- Peptide Supplements and Their Therapeutic Applications in Sports MedicineTewari K, Liu TP, Im C et al. · Am J Sports Med, 2026 · PMID 42578445 · DOI
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
- Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical reviewReviewCoutinho LFD, DE Oliveira Neves LF, Camilo RP · J Sports Med Phys Fitness, 2026 · PMID 41880199 · DOI
Top 8 of 33 results, by relevance. See all on PubMed.
Search query "CJC-1295"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 91971820 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | CJC-1295 |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.